Titlebook: Vascular Disruptive Agents for the Treatment of Cancer; Tim Meyer Book 2010 Springer Science+Business Media, LLC 2010 CT.angiogenesis.canc

只看該作者 · 發(fā)表于 2025-3-27 02:07:36

ASA404 (DMXAA): New Concepts in Tumour Vascular Targeting Therapy

只看該作者 · 發(fā)表于 2025-3-27 06:12:06

Vascular Disruptive Agents in Combination with Radiotherapy

只看該作者 · 發(fā)表于 2025-3-27 12:21:12

Vascular Disruptive Agents for the Treatment of Cancer

只看該作者 · 發(fā)表于 2025-3-27 14:43:16

Vascular Disruptive Agents for the Treatment of Cancer978-1-4419-6609-4

只看該作者 · 發(fā)表于 2025-3-27 17:46:11

只看該作者 · 發(fā)表于 2025-3-28 00:52:53

只看該作者 · 發(fā)表于 2025-3-28 03:42:30

只看該作者 · 發(fā)表于 2025-3-28 08:27:02

Henry C. Mandeville,Peter J. Hoskinntibody molecules with significant affinity for that particular antigen. The former instructional theories of antibody formation clearly were rendered obsolete by this concept. Many scholars attribute the subsequent formal proof of clonal selection to Raff et al. (.).

只看該作者 · 發(fā)表于 2025-3-28 11:55:36

lities used to assess the efficacy of these agents are examiAngiogenesis (formation of new vessels from pre-existing ones) is a crucial early event in the process of tumor development. New vessels supply the tumor with nutrients that are needed for further local growth and enable distant metastases

		自動登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點評	投稿經(jīng)驗總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學	Yale Uni.	Stanford Uni.
\|Archiver\|手機版\|小黑屋\| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-5 20:57
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved